| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| P865151 | MACKLIN | 普鲁氯嗪二马来酸盐 | 98% | 240元/1g; 1088元/5g; | 展开 |
|
| P766741 | MACKLIN | 普鲁氯嗪二马来酸盐 | 10mM in DMSO | 116元/1ml; | 展开 |
|
| P2368 | TCI | Prochlorperazine Dimaleate | >98.0%(T)(HPLC) | 535元/5G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(T)(HPLC) | | 分子式/分子量 | C20H24ClN3S·2C4H4O4 = 606.09 | | 外观与形状(20℃) | 固体 | | 应避免的情况 | 光 | | 相关CAS RN | 58-38-8 | | Reaxys-RN | 3861788 | | PubChem物质ID | 354335064 | | Merck Index (14) | 7761 | | MDL编号 | MFCD00069330 |
技术规格 | Appearance | White to Orange to Green powder to crystal | | Purity(HPLC) | min. 98.0 %(Prochlorperazine + Maleate) | | Purity(Nonaqueous Titration) | min. 98.0 % |
物性(参考值) | 熔点 | 194 ℃(dec.) | | 最大吸收波长 | 313(MeOH) nm | | 水溶性 | 不溶 | | 溶解性(不溶于) | 乙醇,二乙醚 |
安全信息 | 图形或危害标志 |   | | 信号词 | 危险 | | 危险性说明 | H302 : 吞咽有害。 H360 : 可能对生育能力或胎儿造成伤害。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P270 : 使用本产品时不要进食、饮水或吸烟。 P202 : 在阅读并明了所有安全措施前切勿搬动。 P201 : 使用前取得专用说明。 P264 : 作业后彻底清洗皮肤。 P280 : 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P308 + P313 : 如接触到或有疑虑:求医/就诊。 P301 + P312 + P330 : 如误吞咽:如感觉不适,呼叫急救中心/医生。漱口。 P405 : 存放处须加锁。
|
相关法规 |
| P3200000 | | Prochlorperazine maleate | European Pharmacopoeia (EP) Reference Standard | 1559.78元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 Phenothiazine antipsychotic; D2 dopamine receptor antagonist; antispasmodic 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C20H24ClN3S · 2C4H4O4 | | 分子量 | 606.09 | | MDL编号 | MFCD00069330 | | PubChem化学物质编号 | 329820164 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O.CN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1 | | InChI | 1S/C20H24ClN3S.2C4H4O4/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24;2*5-3(6)1-2-4(7)8/h2-3,5-8,15H,4,9-14H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1- | | InChI key | DSKIOWHQLUWFLG-SPIKMXEPSA-N | | Gene Information | human ... DRD2(1813) |
安全信息 | 象形图 |   | | 警示用语: | Warning | | 危险声明 | H302 - H336 - H361d - H362 | | 预防措施声明 | P202 - P260 - P263 - P264 - P301 + P312 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Lact. - Repr. 2 - STOT SE 3 | | 靶器官 | Central nervous system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| P9178 | Sigma-Aldrich | Prochlorperazine dimaleate salt | | 826.84元/5 G; | 展开 |
产品说明 包装 5 g in poly bottle 生化/生理作用 Prochlorperazine is an anti-nausea and neuroleptic agent. It is known to cause neuropsychiatric side effects. Prochlorperazine inhibits the action of dopamine in the central nervous system. It acts as an antiemetic drug and prevents vomiting and stimulates sleep. Prochlorperazine is useful as a tranquilizer in the treatment of schizophrenia and nonpsychotic anxiety. Phenothiazine antipsychotic; D2 dopamine receptor antagonist; antispasmodic 特点和优势 This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here. 基本信息 | 经验(实验)分子式 | C20H24ClN3S · 2C4H4O4 | | 分子量 | 606.09 | | EC 号 | 201-511-3 | | MDL编号 | MFCD00069330 | | PubChem化学物质编号 | 57654570 | | NACRES | NA.77 |
产品性质 | 质量水平 | 200 | | 溶解性 | H2O: slightly soluble 0.3 mg/mL 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 2.3 mg/mL methanol: soluble | | 创始人 | GlaxoSmithKline | | SMILES string | OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O.CN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1 | | InChI | 1S/C20H24ClN3S.2C4H4O4/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24;2*5-3(6)1-2-4(7)8/h2-3,5-8,15H,4,9-14H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1- | | InChI key | DSKIOWHQLUWFLG-SPIKMXEPSA-N | | Gene Information | human ... DRD2(1813) |
安全信息 | 象形图 |   | | 警示用语: | Warning | | 危险声明 | H302 - H336 - H361d - H362 | | 预防措施声明 | P202 - P260 - P263 - P264 - P301 + P312 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Lact. - Repr. 2 - STOT SE 3 | | 靶器官 | Central nervous system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
|
| PHR3114 | Supelco | Prochlorperazine maleate | pharmaceutical secondary standard, certified reference material | 2317.45元/500 mg; | 展开 |
产品说明 一般描述 Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards 生化/生理作用 Phenothiazine antipsychotic; D2 dopamine receptor antagonist; antispasmodic 分析说明 These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. 其他说明 This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. 附注 To see an example of a Certificate of Analysis for this material enter LRAC7715 in the Documents slot below. This is an example certificate only and may not be the lot that you receive. 基本信息 | 经验(实验)分子式 | C20H24ClN3S · 2C4H4O4 | | 分子量 | 606.09 | | MDL编号 | MFCD00069330 |
产品性质 | 等级 | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | 包装 | pkg of 500 mg | | application(s) | pharmaceutical | | 药典可追溯性 | traceable to USP 1566001 | | 储存温度 | 2-8℃ | | SMILES string | OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O.CN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1 | | InChI | 1S/C20H24ClN3S.2C4H4O4/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24;2*5-3(6)1-2-4(7)8/h2-3,5-8,15H,4,9-14H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1- | | InChI key | DSKIOWHQLUWFLG-SPIKMXEPSA-N |
安全信息 | 象形图 |   | | 警示用语: | Warning | | 危险声明 | H302 - H336 - H361d - H362 | | 预防措施声明 | P202 - P260 - P263 - P264 - P301 + P312 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Lact. - Repr. 2 - STOT SE 3 | | 靶器官 | Central nervous system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP638 | | Prochlorperazine maleate | British Pharmacopoeia (BP) Reference Standard | 1861.35元/100 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 Phenothiazine antipsychotic; D2 dopamine receptor antagonist; antispasmodic 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C20H24ClN3S · 2C4H4O4 | | 分子量 | 606.09 | | EC 号 | 201-511-3 | | MDL编号 | MFCD00069330 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O.CN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1 | | InChI | 1S/C20H24ClN3S.2C4H4O4/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24;2*5-3(6)1-2-4(7)8/h2-3,5-8,15H,4,9-14H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1- | | InChI key | DSKIOWHQLUWFLG-SPIKMXEPSA-N | | Gene Information | human ... DRD2(1813) |
安全信息 | 象形图 |   | | 警示用语: | Warning | | 危险声明 | H302 - H336 - H361d - H362 | | 预防措施声明 | P202 - P260 - P263 - P264 - P301 + P312 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Lact. - Repr. 2 - STOT SE 3 | | 靶器官 | Central nervous system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1566001 | USP | Prochlorperazine maleate | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 Phenothiazine antipsychotic; D2 dopamine receptor antagonist; antispasmodic 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C20H24ClN3S · 2C4H4O4 | | 分子量 | 606.09 | | MDL编号 | MFCD00069330 | | PubChem化学物质编号 | 329750959 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | OC(=O)\C=C/C(O)=O.OC(=O)\C=C/C(O)=O.CN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1 | | InChI | 1S/C20H24ClN3S.2C4H4O4/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24;2*5-3(6)1-2-4(7)8/h2-3,5-8,15H,4,9-14H2,1H3;2*1-2H,(H,5,6)(H,7,8)/b;2*2-1- | | InChI key | DSKIOWHQLUWFLG-SPIKMXEPSA-N | | Gene Information | human ... DRD2(1813) |
安全信息 | 象形图 |   | | 警示用语: | Warning | | 危险声明 | H302 - H336 - H361d - H362 | | 预防措施声明 | P202 - P260 - P263 - P264 - P301 + P312 - P308 + P313 | | 危险分类 | Acute Tox. 4 Oral - Lact. - Repr. 2 - STOT SE 3 | | 靶器官 | Central nervous system | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|